Skip to content

TRPC6 Nucleic Acid Amplification Test Kit (Fluorescent PCR)Clinical Trial

TRPC6 Nucleic Acid Amplification Test Kit (Fluorescent PCR)Clinical Trial

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500095239
Enrollment
Unknown
Registered
2025-01-03
Start date
2020-10-16
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer's disease

Interventions

Gold Standard:The first step is to identify cognitive impairment, which is the prerequisite for the diagnosis of AD. The second step is to rule out non-AD induced cognitive impairment through auxiliar
Index test:Produ

Sponsors

Zhongshan Hospital Affiliated to Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1) Age 50 to 90 (including 50 years old and 90 years old), gender is not limited; 2) The subjects have primary school education or above or equivalent ability, and are able to complete the cognitive ability measurement and other tests stipulated in the program; 3) Can provide 4ml of blood; 4) For voluntary participation, if the subject cannot sign the informed consent in person due to limited cognitive ability or other reasons, the subject is allowed to leave the signature blank and explain the reason. The legal guardian shall sign the reason explanation, and the legal guardian shall sign the informed consent. 5) If AD subjects are enrolled, the following conditions should also be met: a) memory loss of at least 12 months; b) Patients with cognitive impairment determined by MMSE (the criteria for patients with mild, moderate or severe disease were determined by Clinical Dementia Degree Scale (CDR), 0.5-1: mild; 2: moderate; 3: heavy); c) Hajinsky Ischemia Scale (HIS) total score <=4 points; d) Hamilton Depression Scale (17-item edition) total score<=7; e)He was clinically diagnosed as an AD patient.

Exclusion criteria

Exclusion criteria: 1) Subjects deemed unsuitable for participation in this experiment by the investigator based on professional knowledge; 2)MMSE score=3. d) Have suffered from cerebrovascular, epilepsy, Parkinson's disease and other central nervous system diseases; e) People who have suffered from psychotic disorders such as bipolar disorder, major depression or delirium; f) The presence of uncorrectable visual and hearing disorders and inability to complete neuropsychological tests and scales; g) Memory impairment and related symptoms that can be explained by other diseases.

Design outcomes

Primary

MeasureTime frame
Relative expression of Transient receptor potential canonical 6;Sensitivity;Specificity;

Countries

China

Contacts

Public ContactChunjiu Zhong

Zhongshan Hospital Affiliated to Fudan University

zhongcj@163.com+86 130 0180 9740

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026